FDMT: 4D Molecular Therapeutics, Inc. Stock

by  •  • Comments Off on FDMT: 4D Molecular Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1,298.89
Enterprise Value ($M) 1,049.78
Book Value ($M) 307.83
Book Value / Share 6.02
Price / Book 4.22
NCAV ($M) 264.53
NCAV / Share 5.17
Price / NCAV 4.91

Profitability (mra)
Return on Invested Capital (ROIC) -0.31
Return on Assets (ROA) -0.41
Return on Equity (ROE) -0.44

Liquidity (mrq)
Quick Ratio 15.65
Current Ratio 15.65

Balance Sheet (mrq) ($M)
Current Assets 296.59
Assets 339.89
Liabilities 32.06
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 20.72
Operating Income -112.87
Net Income -100.84

Cash Flow Statement (mra) ($M)
Cash From Operations -75.79
Cash from Investing 115.72
Cash from Financing 156.83

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Venrock Healthcare Capital Partners III, L.P. 8.90 52.38
02-14 13G/A Biotechnology Value Fund L P 9.40 0.00
02-14 13G/A Deep Track Capital, LP 5.34 -14.02
02-14 13G/A Kirn David 4.70 0.52
02-14 13G/A Ra Capital Management, L.p. 9.70 49.23
02-13 13G/A Janus Henderson Group Plc 7.20 110.96
01-25 13G/A BlackRock Inc. 8.10 38.11
01-08 13G/A Viking Global Investors Lp 11.20 21.59

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 71,307 304,765 23.40
2024-05-01 125,433 472,340 26.56
2024-04-30 55,902 163,498 34.19
2024-04-29 61,569 146,657 41.98

(click for more detail)

Similar Companies
ERAS – Erasca, Inc. EWTX – Edgewise Therapeutics, Inc.
EXEL – Exelixis, Inc. FGEN – FibroGen, Inc.
FNCH – Finch Therapeutics Group, Inc.


Financial data and stock pages provided by
Fintel.io